IMB Dx, Inc.

₩2,315As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:461030Healthcare
Country South Korea
PE (Fwd) •••
TSR 3Y CAGR (56.03%)
Div yield —
ROE (28.97%)
Biotechnology
Beta (5Y) 0.60
PE TTM —
TSR TTM (78.88%)
Mkt cap ₩32.45B
ROIC (20.31%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩2,594
12.04%
(14.97%)
Hold 10|12|9|5|8
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
29.62
31.47
32.03
34.37
1.71%
6.21%
4.16%
13.86%
Revenue₩B
4.354
4.365
4.347
4.362
10.93%
7.53%
4.01%
3.40%
Peers (US$23.93M)
Cap (US$)
PE
33.87M
—
24.17M
—
Capital
TTM
5Y
10Y
Leveragex
1.641
0.092
0.077
EBIT/Intx
0.343
0.078
0.073
Own earn%
(16.63)
99.23
62.85
Sh yield%
26.30
40.23
38.65
Owners
Insiders/Inst%
9.30
74.55
Short interest%
0.91
SBC / revenue%
2.40
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
23–27
$1 testx
—
Incr. ROIC%
4